Navigation Links
Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Date:10/1/2013

E Phase III trial
  • Lead Author: Xavier Forns, Hospital Clinic, Barcelona, Spain
  • Adding simeprevir to peginterferon/ribavirin for HCV shortens time with patient-reported symptoms and impairment in quality of life: Results from the simeprevir Phase III QUEST 1, QUEST 2, and PROMISE studies
    • Lead Author: Jane A. Scott, Janssen
  • Simeprevir (TMC435) with peginterferon/ribavirin for treatment of chronic HCV genotype 1 infection in treatment-naive patients: Efficacy in difficult-to-treat patient sub-populations in the QUEST-1 and 2 Phase III trials
    • Lead Author: Ira M. Jacobson, Weill Cornell Medical College, New York, USA
  • Resistance analyses of HCV isolates from patients treated with simeprevir in Phase 2b/3 studies
    • Lead Author: Oliver Lenz, Janssen
  • The relative efficacy and safety of simeprevir-based triple therapy compared to boceprevir and telaprevir in treatment naive patients chronically infected with genotype-1 hepatitis C virus: Bayesian network meta-analyses
    • Lead Author: Peter A. Bryden, Oxford Outcomes

Full session details and data presentation listings for the 2013 AASLD Annual Meeting can be found at http://www.aasld.org/livermeeting.

About Si
'/>"/>

SOURCE Janssen R&D Ireland
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
2. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
3. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
4. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
5. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
6. U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
7. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
8. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
9. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
10. Bulgaria Launches Development of National Hepatitis Plan
11. Major Breakthrough in Hepatitis C Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... marketplace, innovative consumer research and marketing communication tools ... rich and globally competitive – consequently consumers, desires, ... In this environment, market research groups across ... research and marketing communication tools. However, the adoption ...
(Date:12/19/2014)... 18, 2014 Research and Markets ... the "Micro Market Monitor: North American Dermatology ... http://photos.prnewswire.com/prnh/20130307/600769 ... steadily, which has resulted in fueling the overall ... main purpose of these dermatology devices is to ...
(Date:12/19/2014)... Dec. 18, 2014 Baptist Health Lexington is the ... to receive full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation ... Atrial fibrillation is the most common cardiac arrhythmia and ... cases can lead to stroke and possible death. More than ... have atrial fibrillation and the numbers are rapidly increasing ...
Breaking Medicine Technology:Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3
... SEATTLE, May 30, 2012  Aequus BioPharma, Inc. ("Aequus"), a ... and MTA: CTIC), announced today that its GlycoPolymer technology ... AQB-101 drug candidate, was selected for an oral presentation ... The meeting will be held on May 28-30, 2012, ...
... Medical Center (DMC) and Henry Ford Health System (HFHS) ... renewal and bring jobs to the city of Detroit. ... As part of the economic recovery effort, DMC and ... Health, enabling the company to relocate a medical products ...
Cached Medicine Technology:Cell Therapeutics' Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs 2Cell Therapeutics' Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs 3Cell Therapeutics' Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs 4Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal 2Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal 3Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal 4
(Date:12/22/2014)... 2014 NAPW honors ... of the Year. She is recognized with this prestigious ... recognized networking organization of professional women in the country, ... of Professional Women is a vibrant networking community with ... Ms. Kreider is passionate and committed to best practices ...
(Date:12/22/2014)... DC (PRWEB) December 22, 2014 ... Leadership Conference, next month in San Antonio, ... to address dynamics that often stand in the ... and competition. , This premier faculty development ... for Transformational Leadership, whose mission is to assist ...
(Date:12/21/2014)... Recently, BambooFlooringChina.com, a famous bamboo lumber supplier, has ... and launched a bamboo flooring promotion with great discounts, ... 30, 2015. , According to the CEO of the ... available today; it has a highly distinctive grain with ... woven bamboo is made by a unique manufacturing process ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Khanna Vision ... a guest at the Aspen Helicopters holiday event for ... a Santa with sleigh, flown by an aspen helicopter ... invisible; only Santa with sleigh was visible.(please see accompanying ... and night. Dr.Khanna has helped many pilots with Pi ...
(Date:12/21/2014)... December 21, 2014 Hundreds of ... liability claims involving a class of Type 2 ... move forward in a federal multidistrict litigation now ... California, Bernstein Liebhard LLP reports. According to an ... a data cut-off date of February 27, 2014 ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 3Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 4
... Chemistry and NYU Langone Medical Center have developed a ... many types of cancer. The compound is described in ... Biology. The researchers examined signaling by ... major underlying cause of various developmental disorders and diseases, ...
... , SATURDAY, July 16 (HealthDay News) -- You may ... and just laze around outside, but don,t overdo it: Overexposure to ... Agency warns. On average, heat waves kill more people each ... one American dies every hour from skin cancer, the most common ...
... residents taking certain antidepressant medications are at an increased risk ... new prescription or a dose increase of their current drug, ... Research of Hebrew SeniorLife, an affiliate of Harvard Medical School., ... the study found that nursing home residents have a ...
... July 15 (HealthDay News) -- Binge drinking can damage ... environment or their surroundings) at a critical time when ... study. And, girls may be especially vulnerable ... researchers said. "Even though adolescents might physically ...
... are 22 percent less likely to receive comprehensive primary ... research from the University of Michigan Medical School. ... many of whom belong to the most vulnerable groups, ... This includes children covered by Medicaid and the Children,s ...
... -- One way to avoid overeating at your favorite restaurant may ... eating out, people who used a large fork for bigger bites ... findings released online in advance of publication in an upcoming print ... In conducting the field study in an Italian restaurant, Arul Mishra, ...
Cached Medicine News:Health News:Nursing home residents at heightened risk of falling in the days following 2Health News:Binge Drinking May Impair Teen Brain Development 2Health News:Children with public health insurance less likely to receive comprehensive primary care 2Health News:Want to Eat Less? Try a Bigger Fork 2
... CardioSEAL is a second generation device, ... was tested in over 700 patients beginning ... of leading pediatric cardiologists who perform these ... computer simulations, on the engineering bench, and ...
... YAG laser YC-1600 is a lightweight, compact, ... and clinical performance., ,Key Features, , ... Model ,Further weight reduction has been made ... office.,, Aiming Beam Rotation ,(360 degrees ...
... delivers a solid-state green laser ... and plugs into any standard ... and extreme portability, the unit ... Nidek Phaco Emulsification System CV-24000 ...
... is an effective angina relief ... poor targets. Because it is ... the CO2 Heart Laser 2 ... timely operative decisions to revascularize ...
Medicine Products: